Genomic Correlates of DNA Damage in Breast Cancer Subtypes
Among the described druggable vulnerabilities, acting on the DNA repair mechanism has gained momentum, with the approval of PARP inhibitors in several indications, including breast cancer. However, beyond the mere presence of <i>BRCA1/BRCA2</i> mutations, the identification of additional...
Main Authors: | Esther Cabañas Morafraile, Javier Pérez-Peña, Jesús Fuentes-Antrás, Aránzazu Manzano, Pedro Pérez-Segura, Atanasio Pandiella, Eva M. Galán-Moya, Alberto Ocaña |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-04-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/13/9/2117 |
Similar Items
-
Molecular mechanisms of fanconi anemia / [electronic resource]
by: Kirk, Sandra H., et al.
Published: (2006) -
Regulation of the Fanconi Anemia DNA Repair Pathway by Phosphorylation and Monoubiquitination
by: Masamichi Ishiai
Published: (2021-11-01) -
Fanconi Anemia Patients from an Indigenous Community in Mexico Carry a New Founder Pathogenic Variant in <i>FANCG</i>
by: Pedro Reyes, et al.
Published: (2022-02-01) -
<i>BRCA2</i> Haploinsufficiency in Telomere Maintenance
by: Soffía R. Gunnarsdottir, et al.
Published: (2021-12-01) -
Differential Expression of <i>BARD1</i> Isoforms in Melanoma
by: Lorissa I. McDougall, et al.
Published: (2021-02-01)